Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 29, 2022	Jan. 30, 2021	Feb. 01, 2020
Cash flows from operating activities:
Net income (loss)	$ 56,713	$ (64,538)	$ (7,796)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
Recognition of accumulated foreign currency translation adjustment			792
Amortization and write-off of deferred debt issuance costs	1,179	146	139
Impairment of assets	(2,344)	14,841	889
Depreciation and amortization	17,226	21,477	24,563
Stock compensation expense	1,229	1,446	1,922
Board of directors stock compensation	374	382	569
Changes in operating assets and liabilities:
Accounts receivable	4,306	(197)	(1,174)
Inventories	3,264	17,392	4,417
Prepaid expenses and other current assets	(2,926)	7,194	1,252
Other assets	407	613	1,797
Accounts payable	(1,926)	(4,672)	(2,655)
Operating leases, net	(14,959)	(2,440)	(4,254)
Accrued expenses and other liabilities	12,998	7,128	(4,658)
Net cash provided by (used for) operating activities	75,541	(1,228)	15,803
Cash flows from investing activities:
Additions to property and equipment, net	(5,272)	(4,243)	(13,399)
Net cash used for investing activities	(5,272)	(4,243)	(13,399)
Cash flows from financing activities:
Proceeds from issuance of common stock from private direct offering, net of offering costs	4,375
Proceeds from new FILO loan	17,500
Repayment of FILO loans	(32,500)
Net borrowings (repayments) under credit facility	(59,733)	20,155	(2,690)
Debt extinguishment costs	(1,111)
Debt issuance costs	(1,200)	(25)
Proceeds from the exercise of stock options	776
Tax withholdings paid related to net share settlements of RSUs	(1,867)		(244)
Net cash provided by (used for) financing activities	(73,760)	20,130	(2,934)
Net increase (decrease) in cash and cash equivalents	(3,491)	14,659	(530)
Cash and cash equivalents:
Beginning of period	18,997	4,338	4,868
End of period	$ 15,506	$ 18,997	$ 4,338